Does The Move In Bruker Stock Change Anything?

For questions about this article or underlying research, email help@trefis.com.

Bruker (BRKR) shares rose 70.1% from April 29 to October 26, 2026, while the S&P 500 gained 8.2%. A May 7 report said the stock climbed after first-quarter results beat estimates, supported by growth in Europe and strong bookings. So how much of that gain came from Bruker selling more, and how much from investors paying more for the same sales?

Investors Now Pay More For Bruker’s Sales

Stock prices generally rise either because a company increases its sales or because investors agree to pay more for each dollar of existing business. Bruker’s sales barely moved. The company posted $3.5 billion in revenue over the four quarters to June 2026, up 1.6% from a year earlier. Nearly all of the gain therefore came from a higher price on about the same sales.

Investors now pay 2.5 times sales for Bruker stock, against 3.2 for the S&P 500. On September 30, 2025, the price was 1.4 times sales, marking its lowest level at any quarter end in ten years.

Bruker did not rise alone, though it outpaced peers such as Agilent Technologies, which gained 59% over the same dates. The stock’s biggest one-day move during this window was a 21.8% fall on August 4, the day of its second-quarter report. Yet the shares still reached a one-year closing high on September 30, 2026.

Bruker’s Operating Profit Has Picked Up

Bruker reported a 9.9% operating margin before a noncash goodwill charge in the second quarter of fiscal 2026, up from 3.3% a year earlier. Management said its own adjusted margin rose on U.S. tariff refunds and cost-saving actions. Those actions saved about $30 million in that quarter. The quarter still ended in a net loss of $52 million, which included a noncash goodwill charge of $135 million for the automation and spatial biology businesses.

Bruker is also taking in more orders. Management said on the August 4 call that bookings in its Scientific Instruments segment grew 10% on an organic basis, a measure that excludes currency moves and acquisitions. For four straight quarters, that segment has taken in more orders than it billed. Orders for its semiconductor tools and energy research technologies each grew more than 50% from a year earlier.

Organic Growth Forecast For Bruker Has Not Changed

Management still expects organic revenue growth of 1% to 2% for 2026, keeping the range unchanged on the August 4 call. On that call, the company said it expected third-quarter organic revenue to be roughly flat to up slightly, with about $20 million of planned revenue shifting into the fourth quarter to meet semiconductor customers’ delivery requirements.

Over a longer stretch, Bruker’s profit margin remains far below where it stood three years ago. The company recorded a 7.6% operating margin over the four quarters to June 2026, compared with 18.2% in the four quarters to June 2023.

The stock move therefore changed the price investors pay for Bruker’s sales far more than the business behind them. Bruker’s revenue growth is the number to watch when it reports its third quarter, expected in November 2026.

Is Too Much Of Your Wealth Riding On One Stock?

Bruker holders just watched the stock move sharply higher. When one position grows into a large part of your wealth, a sharp fall can hurt your whole plan, and selling to spread the money out can bring a large tax bill. Our partner advisory firm offers a free strategy review of ways to protect a concentrated position and unwind it with less tax.

Request A Free Strategy Review

Spot an error or want more like this? Tell us in 10 seconds.